202 related articles for article (PubMed ID: 34033941)
1. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering.
Jørgensen NO; Kjøbsted R; Larsen MR; Birk JB; Andersen NR; Albuquerque B; Schjerling P; Miller R; Carling D; Pehmøller CK; Wojtaszewski JFP
Mol Metab; 2021 Sep; 51():101259. PubMed ID: 34033941
[TBL] [Abstract][Full Text] [Related]
2. Compound- and fiber type-selective requirement of AMPKγ3 for insulin-independent glucose uptake in skeletal muscle.
Rhein P; Desjardins EM; Rong P; Ahwazi D; Bonhoure N; Stolte J; Santos MD; Ovens AJ; Ehrlich AM; Sanchez Garcia JL; Ouyang Q; Yabut JM; Kjolby M; Membrez M; Jessen N; Oakhill JS; Treebak JT; Maire P; Scott JW; Sanders MJ; Descombes P; Chen S; Steinberg GR; Sakamoto K
Mol Metab; 2021 Sep; 51():101228. PubMed ID: 33798773
[TBL] [Abstract][Full Text] [Related]
3. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle.
Bultot L; Jensen TE; Lai YC; Madsen AL; Collodet C; Kviklyte S; Deak M; Yavari A; Foretz M; Ghaffari S; Bellahcene M; Ashrafian H; Rider MH; Richter EA; Sakamoto K
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E706-E719. PubMed ID: 27577855
[TBL] [Abstract][Full Text] [Related]
5. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
6. AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle.
Drake JC; Alway SE; Hollander JM; Williamson DL
Am J Physiol Regul Integr Comp Physiol; 2010 Dec; 299(6):R1546-54. PubMed ID: 20844264
[TBL] [Abstract][Full Text] [Related]
7. Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle.
Glund S; Treebak JT; Long YC; Barres R; Viollet B; Wojtaszewski JF; Zierath JR
Endocrinology; 2009 Feb; 150(2):600-6. PubMed ID: 18818284
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators.
Lai YC; Kviklyte S; Vertommen D; Lantier L; Foretz M; Viollet B; Hallén S; Rider MH
Biochem J; 2014 Jun; 460(3):363-75. PubMed ID: 24665903
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle.
Ho RC; Fujii N; Witters LA; Hirshman MF; Goodyear LJ
Biochem Biophys Res Commun; 2007 Oct; 362(2):354-9. PubMed ID: 17709097
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle.
Hunter RW; Treebak JT; Wojtaszewski JF; Sakamoto K
Diabetes; 2011 Mar; 60(3):766-74. PubMed ID: 21282366
[TBL] [Abstract][Full Text] [Related]
11. AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle.
de Laat MA; Robinson MA; Gruntmeir KJ; Liu Y; Soma LR; Lacombe VA
Vet J; 2015 Sep; 205(3):381-6. PubMed ID: 26116041
[TBL] [Abstract][Full Text] [Related]
12. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
13. AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Nimal S; Longnus SL; Van Obberghen E; Hainault I; Foufelle F; Kahn R; Braun U; Leitges M; Farese RV
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E179-92. PubMed ID: 19887597
[TBL] [Abstract][Full Text] [Related]
14. The ULK1/2 and AMPK Inhibitor SBI-0206965 Blocks AICAR and Insulin-Stimulated Glucose Transport.
Knudsen JR; Madsen AB; Persson KW; Henríquez-Olguín C; Li Z; Jensen TE
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231045
[TBL] [Abstract][Full Text] [Related]
15. Effect of AICAR treatment on glycogen metabolism in skeletal muscle.
Aschenbach WG; Hirshman MF; Fujii N; Sakamoto K; Howlett KF; Goodyear LJ
Diabetes; 2002 Mar; 51(3):567-73. PubMed ID: 11872652
[TBL] [Abstract][Full Text] [Related]
16. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
[TBL] [Abstract][Full Text] [Related]
17. Prior AICAR stimulation increases insulin sensitivity in mouse skeletal muscle in an AMPK-dependent manner.
Kjøbsted R; Treebak JT; Fentz J; Lantier L; Viollet B; Birk JB; Schjerling P; Björnholm M; Zierath JR; Wojtaszewski JF
Diabetes; 2015 Jun; 64(6):2042-55. PubMed ID: 25552597
[TBL] [Abstract][Full Text] [Related]
18. Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.
Gaidhu MP; Perry RL; Noor F; Ceddia RB
Mol Endocrinol; 2010 Jul; 24(7):1434-40. PubMed ID: 20501641
[TBL] [Abstract][Full Text] [Related]
19. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle.
Leick L; Fentz J; Biensø RS; Knudsen JG; Jeppesen J; Kiens B; Wojtaszewski JF; Pilegaard H
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E456-65. PubMed ID: 20628026
[TBL] [Abstract][Full Text] [Related]
20. Serum Is Not Necessary for Prior Pharmacological Activation of AMPK to Increase Insulin Sensitivity of Mouse Skeletal Muscle.
Jørgensen NO; Wojtaszewski JFP; Kjøbsted R
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29662023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
